Status:
COMPLETED
Medihoney® Derma Cream Treatment for Mild to Moderate Atopic Dermatitis in Children Study
Lead Sponsor:
Soroka University Medical Center
Conditions:
Atopic Dermatitis
Eligibility:
All Genders
2-18 years
Phase:
PHASE2
Brief Summary
A randomized, open-label trial comparing Medihoney Derma Cream to Hydrocortisone 1% cream. Children between the ages of 2-18 years old diagnosed with mild to moderate atopic dermatitis with an IGA (In...
Detailed Description
A randomized trial comprising children aged 2-18 diagnosed with mild to moderate AD, with an IGA of 2-3 and BSA of 1%-10%, including 30 patients, 20 using Med-D-Cream and 10 as controls using Hydrocor...
Eligibility Criteria
Inclusion
- 2-18 years old
- mild to moderate atopic dermatitis
- an IGA score of 2-3
- BSA score of 1%-10%.
Exclusion
- participation in any clinical trial less than 28 days before the enrollment
- AD-related systemic therapy or phototherapy within 28 days prior to the enrollment
- topical corticosteroids, calcineurin inhibitors, or PDE4 inhibitors use within 7 days prior to the enrollment
Key Trial Info
Start Date :
October 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05276323
Start Date
October 1 2020
End Date
December 31 2021
Last Update
March 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Soroka University Medical Center
Beersheba, Israel